Therefore, preferable blockade of Ito/Kv4.3 and a weak inhibition of IKur/Kv1.5, IKr/hERG, and IKs by allitridi would prolong human atrial action potential and may be effective in anti-atrial fibrillation in humans. Here, KCNH2 is linked to atrial fibrillation.